In the Journals

This feature offers timely executive summaries of the most relevant journals in rheumatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

Omalizumab linked to improved disease activity in SLE

January 16, 2019
Omalizumab is well tolerated and associated with improved disease activity in patients with systematic lupus erythematosus, according to data…
In the Journals

RA risk increased up to fivefold among patients with high CCP levels

January 15, 2019
Among patients who are cyclic citrullinated peptide antibody positive, the risk for rheumatoid arthritis significantly increases as the level of…
In the Journals

Pegloticase effective for rapid resolution of tophi in gout

January 15, 2019
Pegloticase quickly resolved tophi among patients with gout who responded to the treatment, according to data published in Arthritis Research &
In the Journals

Vitamin D deficiency linked to higher disease activity in JIA

January 14, 2019
Among patients with juvenile idiopathic arthritis, vitamin D deficiency is associated with higher disease activity, as well as an increased risk for…
In the Journals

Reverse switch from biosimilar to Remicade produces similar IBD outcomes

January 14, 2019
Patients with inflammatory bowel disease who switched from biosimilar infliximab to Remicade experienced similar results regarding remission, trough…
In the Journals

Medicare Part D could save $14.4B using VA drug prices

January 14, 2019
If Medicare Part D paid prices for prescription medications similar to what the Department of Veterans Affairs pays, there could be an estimated…
In the Journals

Sjögren's syndrome linked to increased cardiovascular comorbidity

January 14, 2019
Primary Sjögren’s syndrome is associated with increased cardiovascular comorbidities, according to data published in Arthritis Care &
In the Journals

Single-infusion rituximab slows RA development in at-risk patients

January 10, 2019
A single 1,000-mg infusion of rituximab significantly slows the development of arthritis among patients at risk for rheumatoid arthritis, according…
In the Journals

Infection risk with abatacept lower than TNF inhibitors in RA

January 9, 2019
Patients with rheumatoid arthritis who are treated with abatacept as a first- or second-line biologic treatment have a lower risk for hospitalized…
In the Journals

Novel app may help anticipate opioid overdose

January 9, 2019
A recently developed app identified changes in breathing patterns that preceded likely opioid overdoses, as well as during an actual overdose…